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Abstract
The formation of amyloid aggregates is related to the onset of a number of human diseases. Recent
studies provide compelling evidence for the existence of related fibrillar structures in bacterial
inclusion bodies (IBs). Bacteria might thus provide a biologically relevant and tuneable system to
study amyloid aggregation and how to interfere with it. Particularly suited for such studies are
protein models for which structural information is available in both IBs and amyloid states. The only
high-resolution structure of an infectious amyloid state reported to date is that of the HET-s prion
forming domain (PFD). Importantly, recent solid-state NMR data indicates that the structure of
HET-s PFD in IBs closely resembles that of the infectious fibrils. Here we present an exhaustive
conformational characterization of HET-s IBs in order to establish the aggregation of this prion in
bacteria as a consistent cellular model in which the effect of autologous or heterologous protein
quality machineries and/or anti-aggregational and anti-prionic drugs can be further studied.
Background
Protein misfolding and aggregation have become very
active areas of research during the last decade. The large
efforts devoted in this period to understand the determi-
nants of polypeptide aggregation are justified by the tight
connection between the formation of insoluble protein
deposits in human tissues and the development of dozens
of conformational diseases. These protein deposits are
constituted mainly by fibrillar structures known as amy-
loids with a common cross-β supramolecular organisa-
tion [1]. Protein aggregation is also an important problem
in biotechnology because during recombinant expression
in prokaryotic systems many heterologous proteins mis-
fold and accumulate as insoluble protein deposits named
inclusion bodies (IBs) limiting in this way the use of bac-
teria for the production of therapeutically relevant pro-
teins [2].
IBs formation has long been regarded as an unspecific
process relaying on the establishment of hydrophobic
contacts [3]. However, an increasing body of evidence
suggests that bacterial IBs share a number of common fea-
tures with the highly ordered and pathogenic amyloid
fibrils linked to human diseases [4]. Both processes have
been shown to be nucleation driven, sequence specific
and lead to the formation of β-sheet enriched structures.
However, the detailed structural characterisation of bacte-
rial aggregates is extremely challenging and to which
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ecule polymerized into amyloids are structurally related
has remained essentially unknown.
Prions represent a particular subclass of amyloids for
which the aggregation process becomes self-perpetuating
in vivo and thus infectious [5]. Fungal prions are infectious
filamentous polymers of proteins. Among these prions are
the [PSI+], [URE3] and [PIN+] yeast prions [6,7] and HET-
s that is a prion of the filamentous fungus Podospora anse-
rina involved in a fungal specific non-self discrimination
phenomenon [8]. HET-s is a 289 residues polypeptide.
Residues 1-227 form a well-folded globular domain in the
soluble HET-s conformation. In contrast the C-terminal
region is highly flexible and unstructured. Previous stud-
ies have identified the C-terminal region of HET-s span-
ning residues 218 to 289 as the prion forming domain
(PFD) responsible for amyloid formation and prion prop-
agation [9,10]. In vivo, this PFD forms dot like aggregates,
whereas a longer version in which the globular domain
has been truncated, comprising residues 157-289, forms
elongated fibrillar aggregates, suggesting that the ability to
adopt this supramolecular organization is conferred in
vivo by the sequences appended to the amyloid core PFD
region [11]. The structure of the infectious amyloid fold of
HET-s PFD have been solved recently by solid state NMR
and represents the only atomic-resolution structure of an
infectious fibrillar conformation reported to date [12].
Under close to physiological conditions, the protein
adopts a β-solenoid structure with two layers of β-strand
per monomer and a characteristic triangular hydrophobic
core (Figure 1) [12]. These in vitro assembled fibrils are
infectious [13,14]. This prion character is strictly associ-
ated to the fibril structure obtained at neutral pH since the
highly ordered, but conformationally different, HET-s
PFD fibrils formed at acidic pH are not infectious [14,15].
HET-s PFD accumulates as IBs when it is over-expressed in
E. coli. Recently, Wasmer and co-workers, used H/D
exchange and solid-state NMR to characterize the HET-s
PFD conformation in IBs, demonstrating that it very
closely resembles to that in the fibrils, explaining why
HET-s PFD IBs are infectious [16]. These results strongly
suggest that bacterial cells expressing the infectious form
of this eukaryotic prion could provide a simple and pow-
erful system to study how the autologous or heterologous
protein quality machinery modulates the in vivo assembly,
toxicity and infectivity of amyloids. In addition, this cellu-
lar model could be a convenient platform for the screen-
ing of generic anti-amyloid or specific anti-prion
compounds. Towards these aims we present here an
exhaustive biophysical and physicochemical characteriza-
tion of the IBs formed by the different amyloidogenic
forms of HET-s in order to establish which are the confor-
mational signatures of these aggregates in a standard cel-
lular background and culture conditions.
Results and Discussion
HET-s PFD assembles into a -sheet enriched structure in 
bacterial IBs
The aggregation of soluble proteins into amyloid fibrils
invariably results in an increase in their β-sheet content
[1]. In this way, the soluble and unstructured HET-s PFD
undergoes a transition towards a β-sheet enriched confor-
mation upon in vitro fibrillation [14,17]. The far-UV CD
spectrum of HET-s mature fibrils displays a negative band
at ~217 nm characteristic of β-sheet structures [14,17]. In
the CD spectrum of HET-s PFD IBs the band is shifted 6
nm and centred at 223 nm (Figure 2A). This shift in the β-
sheet signal in the far-UV CD spectra of aggregated amy-
loid proteins has been shown to be related to differences
in the macroscopic morphology of the fibrils and thought
to arise from the superposition of the aromatic CD band
on the classical β-sheet CD spectrum as a result of changes
in the stacking of the polypeptide aromatic side-chains in
the fibrils [18]. FTIR spectroscopy allows more accurate
assignment of the secondary structure elements in protein
aggregates than CD. The FTIR spectrum of the infectious
fibrillar form of HET-s PFD is dominated in the amide I
region by a peak at ~1629 cm-1. This signal was associated
to the presence of a cross-β-sheet structure in the fibrils
[14]. The spectrum of HET-s PFD IBs closely resembles
that of the fibrils (Figure 2B and 2C), with a main band at
Three-dimensional structure of the infectious HET-s PFD fibrilsFigure 1
Three-dimensional structure of the infectious HET-s 
PFD fibrils. Ribbon representation the five central mole-
cules corresponding to the lowest energy structure of the 
HET-s PFD heptamer as calculated from NMR restraints 
(PDB ID: 2RNM).Page 2 of 10
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sheet architecture in these intracellular aggregates.
Amyloid properties of HET-s IBs
We used the amyloid specific dye Congo Red (CR) to ver-
ify that the detected IBs β-sheet structures display typical
amyloid properties. The absorbance of CR increases and
the spectrum maximum red-shifts to ~508 nm in the pres-
ence of HET-s PFD IBs (Figure 3A). This spectral change is
identical to that observed in the presence of the infectious
fibrils formed by the prion domain [14]. In addition, the
difference spectrum between the dye in the presence and
absence of IBs allows detecting the characteristic amyloid
band at ~540 nm (Figure 3B). HET-s amyloid fibrils [19]
exhibit CR birefringence, which is accepted to be one of
the most stringent diagnostics for amyloid conformation
[1]. As shown in Figure 3C and 3D, HETs PFD IBs also
show a strong green-gold birefringence upon incubation
with CR and illumination under cross-polarized light.
The structural properties of the bacterial IBs formed by the
full-length HET-s prion and HET-s (157-289) have not
been explored previously. However, it was shown that
they display a common proteinase K (PK) resistant core
which likely corresponds to the PFD region [16]. There-
fore, one might expect that the IBs formed by these two
proteins would also display amyloid features. In agree-
ment with this hypothesis, both types of IBs bind CR (Fig-
ure 3A and 3B). Interestingly, the change in the CR signal
correlates with the proportion of amyloidogenic versus
non-amyloidogenic regions in the polypeptides. In this
way, the CR signal in the presence of PFD IBs is three fold
that of the dye in the presence of the full-length prion IBs.
The IB-stretch hypothesis postulates that not necessarily
all the polypeptide chain is involved in the network of
contacts that sustain the β-core of an IB but rather that
specific contacts between certain aggregation-prone
regions keep the aggregate in a compact state [20]. For
HET-s, the data suggest that the PFD is responsible for
maintaining the detected IBs β-sheet architecture, as likely
happens in the aggregates formed by the prion in its phys-
iological environment.
A striking characteristic of HET-s PFD infectious fibrils is
that, in contrast to most amyloid structures, they do not
induce Thioflavin-T (Th-T) fluorescence [14], a dye widely
used for amyloid diagnostic. Interestingly, in contrast
with the IBs formed by other amyloidogenic peptides like
the Aβ peptide [21], none of the three assayed HET-s IBs
specifically induces Th-T fluorescence (data not shown).
Overall, HET-s IBs display affinities for amyloid dyes that
closely resemble that of the protein in its infectious fibril-
lar form.
The  fibrillar core of HET-s IBs
Proteinase K is a protease usually used to map the pro-
tected core of amyloid fibrils because in spite of being
highly active against peptidic bonds it cannot attack the
highly packed backbones in amyloid β-sheet structures.
We have shown that PK digestion also allows to reveal the
existence of a fibrillar core in Aβ peptide IBs [21]. We used
the same approach to asses if the presence of a similar
fibrillar material might account for the amyloid confor-
mational properties of HET-s IBs. All purified HET-s IBs
Secondary structure of HET-s PFD IBsFigure 2
Secondary structure of HET-s PFD IBs. (A) Circular 
dichroism spectra, and (B and C) FTIR absorbance and sec-
ond derivative spectra in the amide I region of the spectra 
showing the characteristic spectral bands of β-sheet confor-
mations.Page 3 of 10
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(Figure 4, left panel). The progress of the digestion reac-
tion was followed by monitoring the changes in the solu-
tion turbidity at 350 nm. The reaction reached a plateau
after ~60 min (data not shown). We imaged samples
taken at t1/2. The aggregates were partially digested and the
presence of abundant fibrillar structures could be
observed in the IBs formed by all HET-s polypeptides (Fig-
ure 4, central and right panel). It is important to note that
amyloid fibrils do not form spontaneously from soluble
HET-s in the presence of the PK concentrations used to
digest IBs [see Additional file 1] and therefore that the
observed fibrillar material is not the result of the release
HET-s fragments into solution and its subsequent reas-
sembly. The fibrils are associated with apparently amor-
phous material and in some micrographs fibrils emerging
from the preformed compact IBs are seen. The fibrils
dimensions and morphology are very similar to that of
the infectious amyloid fibrils formed in vitro at pH 7.0: the
elementary fibrils are ~5 nm in diameter and tend to asso-
ciate laterally into bundles or stacks [14,22]. Overall, it
appears that the different HET-s IBs constitute a bacterial
reservoir of amyloid structures that coexist with more dis-
ordered and PK susceptible protein regions.
Stability of HET-s PFD IBs towards chemical denaturation
We have previously characterized the stability of HET-s
PFD fibrils towards chemical denaturation with
Gdn·HCl. At pH 7, we found that the midpoint (m1/2) of
the transition between the aggregated and soluble states of
Congo-Red (CR) binding to different HET-s IBs by UV/Vis spectroscopy and staining and birefringence under cross-polarized light using an optic microscopeFigure 3
Congo-Red (CR) binding to different HET-s IBs by UV/Vis spectroscopy and staining and birefringence under 
cross-polarized light using an optic microscope. (A and B) CR spectral changes in the presence of different HET-s IBs; 
(A) Changes in λmax and intensity in CR spectra in the presence of IBs; (B) Difference absorbance spectra of CR in the presence 
and absence of IBs showing in all cases the characteristic amyloid band at ~540 nm. (C) HET-PFD IBs stained with Congo red 
and observed at 40× magnification and in (D) the same field observed between crossed polarizers displaying the green birefrin-
gence characteristic of amyloid structures.Page 4 of 10
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of ~3.5 M [14]. In a recent study we demonstrated that the
same approach can be used to approximate the stability of
bacterial IBs [23]. This provides us with an opportunity to
compare the strength of the contacts stabilizing HET-s
PFD IBs with that established by the same polypeptide in
the amyloid fibrillar state. IBs denaturation was measured
by monitoring the changes in absorbance at 350 nm in
the presence of 0 to 8 M Gdn·HCl. As for fibrils, we
assumed that only aggregated states contribute signifi-
cantly to the signal. To determine the incubation time
necessary to reach equilibrium we followed the kinetics of
IBs solubilization in the presence of different Gdn·HCl
concentrations. We observed that, as happens in the dena-
turation of globular proteins, both the amplitude and the
fast rate constant of the reaction increased with increasing
chaotropic agent concentrations (Figure 5A). In all cases
the reaction was complete before 10 h of incubation. We
calculated m1/2 for IBs solubilization under equilibrium
conditions (20 h incubation) to be ~1.5 M (Figure 5B).
Therefore, the in vivo formed aggregates are significantly
less resistant than in vitro fibrils to chemical denaturation
[14]. The reduced stability of IBs relative to the fibrils is
not surprising if we take into account the PK digestion
experiments discussed above which show that ordered
stable fibrillar and, amorphous and probably less stables
structures coexist in IBs. The presence of minor contami-
nants might also condition the stability of IBs.
Amyloid seeding capacity of HET-s IBs
The kinetics of amyloid fibril formation usually follow a
sigmoidal curve that reflects a nucleation-dependent
growth mechanism [24]. The assembly of HET-s PFD
fibrils in vitro at pH 7.0 follows this kinetic scheme (Figure
HET-s IBs structure before (left panel) and after 30 min of proteinase K digestion (central and right panel) as monitored by transmission elect onic microscopyFigure 4
HET-s IBs structure before (left panel) and after 30 min of proteinase K digestion (central and right panel) as 
monitored by transmission electronic microscopy.Page 5 of 10
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the initial nuclei on which the polymerization or fibril
growth spontaneously proceeds. This step is considerably
shortened by the presence of preformed fibrils than can
act as seeds for the polymerization reaction. As previously
reported by Wasmer and co-workers [16], the presence of
limited amounts of HET-s PFD IBs also promotes a dra-
matic acceleration in the nucleation rate of soluble HET-s
PFD amyloid formation (Figure 6). Interestingly enough,
the IBs formed by the full-length prion protein and HET-s
157-298 promote exactly the same effect: the lag phase is
shortened from 30 to 10 min and the total reaction time
from 110 to 70 min. To ensure that the increase in aggre-
gation rates results from a faster growth of amyloid mate-
rial and not from the formation of amorphous
assemblies, the morphology of the aggregates present in
seeded solutions was analyzed by EM at the end of the
reaction. As it is shown in Figure 7, independently of the
HET-s IBs used to seed the reaction, the presence of abun-
dant fibrillar structures with a morphology closely resem-
bling that of unseeded fibrils was observed in all cases.
Amyloid formation is a highly specific process that can be
accelerated only by homologous fibrils, but not by fibrils
from unrelated polypeptides. This is because the amino
acid sequence dictates the fibril conformation and it is in
fact the fibril structure which determines seeding ability
[1]. To test if this selectivity also applies in the case of IBs
we performed cross-seeding experiments of soluble HET-s
PFD with the IBs formed by the two amyloidogenic vari-
ants of the Alzheimer's related peptides Aβ40 and Aβ42.
The presence of Aβ IBs does not affect the nucleation or
the elongation rates (Figure 6) confirming that a highly
specific molecular recognition between soluble and aggre-
gated states is indispensable for seeding to occur. There-
fore, the cross-reactivity observed for the different HET-s
forms strongly suggests that the β-solenoid supramolecu-
lar disposition proposed for HET-s PFD IBs [16] is also
present in the bacterial aggregates formed by the full-
length HET-s prion. Structural similarity of the 218-289
region in PFD alone and full length HET-s in vitro amy-
loids was recently evidenced by ssNMR [25].
Conclusion
Prions are misfolded, self-propagating, infectious pro-
teins. The HET-s PFD of Podospora anserina constitutes the
HET-s IBs stabilityFigure 5
HET-s IBs stability. (A) Kinetics of chemical solubilization 
of HET-s PFD IBs at different Gdn·HCl, monitored by a time 
dependent decrease in light scattering at 350. (B) Solubiliza-
tion at the equilibrium of HET-s PFD IBs in the presence of 
increasing concentrations of Gdn·HCl monitored by light 
scattering at 350 nm.
Seeding-dependent maturation of HET-s PFD amyloid growthFigure 6
Seeding-dependent maturation of HET-s PFD amy-
loid growth. The aggregation reaction was seeded with 
HET-s(001-289), HET-s(157-289), HET-s(218-289), Aβ40 or 
Aβ42 IBs. The fibrillar fraction of HET-s PFD is represented 
as a function of time. The formation of HET-s PFD amyloid 
fibrils is accelerated only in the presence of HET-s IBs.Page 6 of 10
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Morphological properties of HET-s PFD aggregates present at the final time point of soluble monomer non-seeded aggregation reactions (top anel) or at the final stage of reactions seeded with HET-s(001-289) (t p-middle pan l), HET-s(157-289) (bot-tom-middle panel) and HET-s(218-289) IBs (bot om pan l) s mon tored by transmi sion lectronic microscopyFigure 7
Morphological properties of HET-s PFD aggregates present at the final time point of soluble monomer non-
seeded aggregation reactions (top panel) or at the final stage of reactions seeded with HET-s(001-289) (top-
middle panel), HET-s(157-289) (bottom-middle panel) and HET-s(218-289) IBs (bottom panel) as monitored 
by transmission electronic microscopy.
Microbial Cell Factories 2009, 8:56 http://www.microbialcellfactories.com/content/8/1/56only model for which the infectious fold is known to date
at atomic resolution. Moreover, the same fold appears to
be conserved in the IBs it forms in bacteria. We show here
that the IBs formed by the full-length prion display very
similar amyloid characteristics, becoming thus an inter-
esting model to study amyloid formation in bacteria. The
formation of prionic infectious folds is known to be
tightly controlled by the cellular folding machinery [26].
For HET-s, this propagation depends on molecular chap-
erones and more specifically on Hsp104 as has been
shown not only in P. anserina but also when this prion is
heterologously expressed in yeast. The data in the present
study supports the use bacterial systems to study how the
very well characterized homologous prokaryotic chaper-
ones, for example ClpB (a Hsp104 homolog), recom-
binant eukaryotic chaperones or small chemical
compounds modulate the formation and structure of
infectious prions in a more simple cellular background.
Although solid state NMR provides a detailed view of the
conformational properties of IBs at the molecular level, it
requires specific equipment, labelling of the proteins,
growing of the bacterial cells in non physiological mini-
mal media and is overall a slow technique not suitable for
large scale screening. The set of biophysical approaches
described in the present work accurately report on the
conformational properties of prionic HET-s IBs allowing
to monitor how bacterial backgrounds modulate their
properties in a faster and simpler manner.
Methods
Protein expression
Plasmids encoding for C-terminally histidine-tagged HET-
s full-length, HET-s(157-289) and HET-s PFD polypep-
tides have been previously described [9,11,19]. They were
cloned into the NdeI and HindIII sites of the pET21a vec-
tor (Novagen) and transformed into BL21(DE3) pLysS
cells. The C-terminal histidine tag does not affect the bio-
logical activity of HET-s in P. anserina [19]. For protein
expression, 10 mL overnight culture of transformed cells
was used to inoculate 2 L of DYT medium, which was fur-
ther incubated at 37°C and 200 rpm. At an OD600 of 0.5,
protein expression was induced with 1 mM of isopropyl-
1-thio-β-D-galactopyranoside for 3 h at 37°C, then the
cultures were centrifuged and the cell pellet frozen at -
20°C.
IB purification
IBs were purified from induced cell extracts by detergent-
based procedures as previously described [27]. Briefly,
cells were harvested by centrifugation at 12 000 × g (at
4°C) for 15 min and resuspended in 200 μL of lysis buffer
(50 mM Tris-Cl pH 8, 1 mM EDTA, 100 mM NaCl), plus
30 μL of 100 mM protease inhibitor PMSF and 6 μL of 10
mg/mL lysozyme. After 30 min of incubation at 37°C
under gentle agitation, NP-40 was added at 1% (v/v) and
the mixture incubated at 4°C for 30 min. Then, 3 μL of
DNase I and RNase from 1 mg/mL stock (25 μg/mL final
concentration) and 3 μL of 1 M MgSO4 were added and
the resulting mixture was further incubated at 37°C for 30
min. Protein aggregates were separated by centrifugation
at 12 000 × g for 15 min at 4°C. Finally, IBs were washed
once with the same buffer containing 0.5% Triton X-100
and once with sterile PBS. After a final centrifugation at 12
000 × g for 15 min, pellets were stored at -20°C until anal-
ysis. The frozen pellets were reconstituted in PBS buffer.
SDS-PAGE analysis revealed that in all cases HET-s pro-
teins were the major polypeptidic components of the
respective aggregates.
Secondary structure determination
ATR FT-IR spectroscopy analyses of HET-s IBs were per-
formed using a Bruker Tensor 27 FT-IR Spectrometer
(Bruker Optics Inc) with a Golden Gate MKII ATR acces-
sory. Each spectrum consists of 20 independent scans,
measured at a spectral resolution of 2 cm-1 within the
1800-1500 cm-1 range. All spectral data were acquired and
normalized using the OPUS MIR Tensor 27 software. Sec-
ond derivatives of the spectra were used to determine the
frequencies at which the different spectral components
were located.
CD spectra were collected in the 200 - 250 nm range at
25°C and measured at a spectral resolution of 1 cm-1, and
a scan rate of 15 nm min-1 using a Jasco 810 spectropola-
rimeter with a quartz cell of 0.1 cm path length.
Chemical denaturation
For stability assays, purified IBs were prepared at OD350 nm
= 1 in PBS solution at pH 7.0 containing selected concen-
trations of guanidine hydrochloride (Gdn·HCl) ranging
from 0 to 8 M. For equilibrium denaturation experiments,
the reactions were allowed to reach equilibrium by incu-
bating them for 20 h at room temperature. The fraction of
soluble protein (fS) was calculated from the fitted values
using equation: fS = 1-((yS-y)/(yS-yA)), where yS and yA are
the absorbance at 350 nm of the soluble and aggregated
protein, respectively, and y is the absorbance of the pro-
tein solution as a function of denaturant concentration.
The value m1/2 was calculated as the denaturant concen-
tration at which fS = 1/2. OD350 nm changes were moni-
tored in a Cary-400 Varian spectrophotometer (Varian
Inc.).
For kinetic experiments, purified IBs were prepared at
OD350 nm = 1 in PBS solution at pH 7.0 containing selected
concentrations of Gdn·HCl. The reaction was monitored
by measuring the changes in OD350 nm. Double-exponen-
tial decay curves were fitted to the data using Sigmaplot
non-linear regression software (Jandel Scientific, SanPage 8 of 10
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derived from these regressions.
Limited proteolysis
HET-s IBs (to a final OD350 nm = 0.125) were digested at
37°C with 10 μg/mL of proteinase K (PK) in pH 7.0 PBS
buffer and the digestion was followed by UV/Vis spectros-
copy at 350 nm. After 30 min of reaction, fractions of the
samples were centrifuged and the insoluble part resus-
pended in water, placed on carbon-coated copper grids,
and left to stand for five minutes. The grids were washed
with distilled water and stained with 2% (w/v) uranyl ace-
tate for another two minutes before analysis using a
HitachiH-7000 transmission electron microscope operat-
ing at accelerating voltage of 75 kV.
Congo Red binding
Congo-Red (CR) interaction with different HET-s IBs was
tested using a Cary100 (Varian) UV/Vis spectrophotome-
ter by recording the absorbance spectra from 375 nm to
675 nm using a matched pair of quartz cuvettes of 1 cm
optical length placed in a thermostated cell holder at
25°C. In order to detect the typical amyloid band at ~540
nm, differential CR spectra in the presence and absence of
protein were used.
HET-s IBs were incubated for 1 h in the presence of 50 μM
CR. After centrifugation (14 000 × g for 5 min), the precip-
itated fraction was placed on a microscope slide and
sealed. The CR birefringence was detected under cross-
polarized light using an optic microscope (Leica DMRB,
Heidelberg, Germany).
Seeding assays
HET-s PFD aggregation from soluble monomer was mon-
itored by measuring the transition from non-aggregated to
aggregated state by UV/Vis spectrophotometry at 350 nm.
In the seeding assay, a solution of different HET-s IBs (to
a final OD350 = 0.125) was also added at the beginning of
the reaction. Cross-seeding assays with Aβ40 and Aβ42 IBs
were performed in the same manner. All experiments were
carried out at 40°C and 1400 rpm with an initial soluble
monomer concentration of 10 μM.
HET-s PFD aggregation process may be studied as an auto-
catalytic reaction using the equation f = ( {exp [(1+ )kt]-
1})/{1+ *exp[(1+ )kt]} under the boundary condition of
t = 0 and f = 0, where k = kea (when a is the protein con-
centration) and  represents the dimensionless value to
describe the ratio of kn to k. By non-linear regression of f
against t, values of  and k can be easily obtained, and from
them the rate constants, ke (elongation constant) and kn
(nucleation constant). The extrapolation of the growth
portion of the sigmoid curve to abscissa (f = 0), and to the
highest ordinate value of the fitted plot, afforded two val-
ues of time (t0 and t1), which correspond to the lag time
and to the time at which the aggregation was almost com-
plete [28].
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RS and SV directed the work and prepared the manuscript,
AE performed experimental work and SJS contributed to
the analysis and interpreation of the data.
Additional material
Acknowledgements
We gratefully thank Dr. Francesc X. Aviles and Dr. Josep Vendrell for lab 
facilities. We thank Dr. Bernd Reif for generously providing us the plasmid 
encoding for Aβ40 peptide. This work has been supported by grants 
BIO2007-68046 (Spanish Ministry for Science and Innovation) and 2009-
SGR 760 (Generalitat de Catalunya).
References
1. Chiti F, Dobson CM: Protein misfolding, functional amyloid,
and human disease.  Annu Rev Biochem 2006, 75:333-366.
2. Ventura S, Villaverde A: Protein quality in bacterial inclusion
bodies.  Trends Biotechnol 2006, 24(4):179-185.
3. de Groot NS, Espargaro A, Morell M, Ventura S: Studies on bacte-
rial inclusion bodies.  Future Microbiol 2008, 3:423-435.
4. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S:
Amyloid-like properties of bacterial inclusion bodies.  J Mol
Biol 2005, 347(5):1025-1037.
5. Prusiner SB: Shattuck lecture--neurodegenerative diseases
and prions.  N Engl J Med 2001, 344(20):1516-1526.
6. Wickner RB: [URE3] as an altered URE2 protein: evidence for
a prion analog in Saccharomyces cerevisiae.  Science 1994,
264(5158):566-569.
7. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T: Prions of
fungi: inherited structures and biological roles.  Nat Rev Micro-
biol 2007, 5(8):611-618.
8. Coustou V, Deleu C, Saupe S, Begueret J: The protein product of
the het-s heterokaryon incompatibility gene of the fungus
Podospora anserina behaves as a prion analog.  Proc Natl Acad
Sci USA 1997, 94(18):9773-9778.
9. Balguerie A, Dos Reis S, Ritter C, Chaignepain S, Coulary-Salin B,
Forge V, Bathany K, Lascu I, Schmitter JM, Riek R, et al.: Domain
organization and structure-function relationship of the HET-
s prion protein of Podospora anserina.  Embo J 2003,
22(9):2071-2081.
10. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH,
Saupe SJ, Riek R: Correlation of structural elements and infec-
tivity of the HET-s prion.  Nature 2005, 435(7043):844-848.
11. Balguerie A, Dos Reis S, Coulary-Salin B, Chaignepain S, Sabourin M,
Schmitter JM, Saupe SJ: The sequences appended to the amyloid
Additional file 1
Effect of Proteinase K on HET-s PFD soluble monomer aggregation. 
Aggregation of HET-s PFD soluble monomer in the absence (top panel) 
and presence of 5 g/mL of proteinase K (bottom panel) as imaged by elec-
tronic microscopy. The aggregation assay was realized at 37°C and pH7 
for 24 h.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2859-8-56-S1.TIFF]Page 9 of 10
(page number not for citation purposes)
Microbial Cell Factories 2009, 8:56 http://www.microbialcellfactories.com/content/8/1/56Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
core region of the HET-s prion protein determine higher-
order aggregate organization in vivo.  J Cell Sci 2004, 117(Pt
12):2599-2610.
12. Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, Meier
BH: Amyloid fibrils of the HET-s(218-289) prion form a beta
solenoid with a triangular hydrophobic core.  Science 2008,
319(5869):1523-1526.
13. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe
SJ: Amyloid aggregates of the HET-s prion protein are infec-
tious.  Proc Natl Acad Sci USA 2002, 99(11):7402-7407.
14. Sabate R, Baxa U, Benkemoun L, Sanchez de Groot N, Coulary-Salin
B, Maddelein ML, Malato L, Ventura S, Steven AC, Saupe SJ: Prion
and non-prion amyloids of the HET-s prion forming domain.
J Mol Biol 2007, 370(4):768-783.
15. Wasmer C, Soragni A, Sabate R, Lange A, Riek R, Meier BH: Infec-
tious and noninfectious amyloids of the HET-s(218-289)
prion have different NMR spectra.  Angew Chem Int Ed Engl 2008,
47(31):5839-5841.
16. Wasmer C, Benkemoun L, Sabate R, Steinmetz MO, Coulary-Salin B,
Wang L, Riek R, Saupe SJ, Meier BH: Solid-State NMR Spectros-
copy Reveals that E. coli Inclusion Bodies of HET-s(218-289)
are Amyloids.  Angew Chem Int Ed Engl 2009, 48(26):4858-4860.
17. Sabate R, Saupe SJ: Thioflavin T fluorescence anisotropy: an
alternative technique for the study of amyloid aggregation.
Biochem Biophys Res Commun 2007, 360(1):135-138.
18. Nyrkova IA, Semenov AN, Aggeli A, Boden N: Fibril stability in
solutions of twisted b-sheet peptides: a new kind of micelli-
zation in chiral systems.  Eur Phys J B 2000, 17:481-497.
19. Dos Reis S, Coulary-Salin B, Forge V, Lascu I, Begueret J, Saupe SJ:
The HET-s prion protein of the filamentous fungus
Podospora anserina aggregates in vitro into amyloid-like
fibrils.  J Biol Chem 2002, 277(8):5703-5706.
20. De Groot NS, Sabate R, Ventura S: Amyloids in bacterial inclui-
son bodies.  Trends Biochem Sci 2009 in press.
21. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, Fernandez-
Busquets X, Ventura S: Inclusion bodies: specificity in their
aggregation process and amyloid-like structure.  Biochim Bio-
phys Acta 2008, 1783(10):1815-1825.
22. Sen A, Baxa U, Simon MN, Wall JS, Sabate R, Saupe SJ, Steven AC:
Mass analysis by scanning transmission electron microscopy
and electron diffraction validate predictions of stacked beta-
solenoid model of HET-s prion fibrils.  J Biol Chem 2007,
282(8):5545-5550.
23. Espargaro A, Sabate R, Ventura S: Kinetic and thermodynamic
stability of bacterial intracellular aggregates.  FEBS Lett 2008,
582(25-26):3669-3679.
24. Jarrett JT, Lansbury PT Jr: Seeding "one-dimensional crystalliza-
tion" of amyloid: a pathogenic mechanism in Alzheimer's
disease and scrapie?  Cell 1993, 73(6):1055-1058.
25. Wasmer C, Schutz A, Loquet A, Buhtz C, Greenwald J, Riek R, Bock-
mann A, Meier BH: The Molecular Organization of the Fungal
Prion HET-s in Its Amyloid Form.  J Mol Biol 2009,
394(1):119-127.
26. Chien P, Weissman JS, DePace AH: Emerging principles of con-
formation-based prion inheritance.  Annu Rev Biochem 2004,
73:617-656.
27. Carrio MM, Cubarsi R, Villaverde A: Fine architecture of bacte-
rial inclusion bodies.  FEBS Lett 2000, 471(1):7-11.
28. Sabate R, Gallardo M, Estelrich J: An autocatalytic reaction as a
model for the kinetics of the aggregation of beta-amyloid.
Biopolymers 2003, 71(2):190-195.Page 10 of 10
(page number not for citation purposes)
